Evoke Pharma Inc Annual Operating Margin in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Evoke Pharma Inc quarterly/annual Operating Margin history and growth rate from 2020 to 2023.
  • Evoke Pharma Inc Operating Margin for the quarter ending September 30, 2024 was -68.5 %, a 59.4% increase year-over-year.
  • Evoke Pharma Inc annual Operating Margin for 2023 was -143 %, a 53.8% increase from 2022.
  • Evoke Pharma Inc annual Operating Margin for 2022 was -310 %, a 38.4% increase from 2021.
  • Evoke Pharma Inc annual Operating Margin for 2021 was -504 %, a 99.1% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -143 +167 +53.8% Jan 1, 2023 Dec 31, 2023
2022 -310 +193 +38.4% Jan 1, 2022 Dec 31, 2022
2021 -504 +56.2K +99.1% Jan 1, 2021 Dec 31, 2021
2020 -56.7K Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.